These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35463194)

  • 21. A Cardiac Magnetic Resonance Study: Comparison of Biventricular Longitudinal Function in Hypertrophic Cardiomyopathy Patients and Normal Individuals.
    Özden Tok Ö; Bingol G; Unlu S; Boyuk F
    Cureus; 2023 Jan; 15(1):e34165. PubMed ID: 36843682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy].
    Maron MS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers.
    Lyon A; Ariga R; Mincholé A; Mahmod M; Ormondroyd E; Laguna P; de Freitas N; Neubauer S; Watkins H; Rodriguez B
    Front Physiol; 2018; 9():213. PubMed ID: 29593570
    [No Abstract]   [Full Text] [Related]  

  • 24. Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.
    Avanesov M; Münch J; Weinrich J; Well L; Säring D; Stehning C; Tahir E; Bohnen S; Radunski UK; Muellerleile K; Adam G; Patten M; Lund G
    Eur Radiol; 2017 Dec; 27(12):5136-5145. PubMed ID: 28616729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management.
    Licordari R; Trimarchi G; Teresi L; Restelli D; Lofrumento F; Perna A; Campisi M; de Gregorio C; Grimaldi P; Calabrò D; Costa F; Versace AG; Micari A; Aquaro GD; Di Bella G
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach.
    Carrick RT; Ahamed H; Sung E; Maron MS; Madias C; Avula V; Studley R; Bao C; Bokhari N; Quintana E; Rajesh-Kannan R; Maron BJ; Wu KC; Rowin EJ
    Heart Rhythm; 2024 Jan; ():. PubMed ID: 38280624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac magnetic resonance radiomics for disease classification.
    Zhang X; Cui C; Zhao S; Xie L; Tian Y
    Eur Radiol; 2023 Apr; 33(4):2312-2323. PubMed ID: 36378251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
    Weng Z; Yao J; Chan RH; He J; Yang X; Zhou Y; He Y
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1392-1402. PubMed ID: 27450876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.
    Hinojar R; Zamorano JL; Gonzalez Gómez A; Plaza Martin M; Esteban A; Rincón LM; Portugal JC; Jimenez Nácher JJ; Fernández-Golfín C
    Clin Cardiol; 2017 Oct; 40(10):853-860. PubMed ID: 28614597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.
    Baeßler B; Mannil M; Maintz D; Alkadhi H; Manka R
    Eur J Radiol; 2018 May; 102():61-67. PubMed ID: 29685546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
    J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance.
    Stankowski K; Figliozzi S; Lisi C; Catapano F; Panico C; Cannata F; Mantovani R; Frontera A; Bragato RM; Stefanini G; Monti L; Condorelli G; Francone M
    J Cardiovasc Dev Dis; 2023 May; 10(6):. PubMed ID: 37367391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk stratification in pediatric hypertrophic cardiomyopathy: Insights for bridging the evidence gap?
    Nakano SJ; Menon SC
    Prog Pediatr Cardiol; 2018 Jun; 49():31-37. PubMed ID: 31097901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.
    Green JJ; Berger JS; Kramer CM; Salerno M
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):370-7. PubMed ID: 22498326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.
    Palumbo P; Masedu F; De Cataldo C; Cannizzaro E; Bruno F; Pradella S; Arrigoni F; Valenti M; Splendiani A; Barile A; Giovagnoni A; Masciocchi C; Di Cesare E
    Radiol Med; 2021 Dec; 126(12):1532-1543. PubMed ID: 34894317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients.
    Riza Demir A; Celik Ö; Sevinç S; Uygur B; Kahraman S; Yilmaz E; Cemek M; Onal Y; Erturk M
    Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12672. PubMed ID: 31152489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtypes and Mechanisms of Hypertrophic Cardiomyopathy Proposed by Machine Learning Algorithms.
    Glavaški M; Preveden A; Jakovljević Đ; Filipović N; Velicki L
    Life (Basel); 2022 Oct; 12(10):. PubMed ID: 36294999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrical storm in hypertrophic cardiomyopathy: Cardiac magnetic resonance and sudden cardiac death risk stratification: a case report.
    Garcia Brás P; Rosa SA; Portugal G; Oliveira MM
    Eur Heart J Case Rep; 2023 Jan; 7(1):ytad010. PubMed ID: 36694873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotyping of hypertensive heart disease and hypertrophic cardiomyopathy using personalized 3D modelling and cardiac cine MRI.
    Chuah SH; Md Sari NA; Chew BT; Tan LK; Chiam YK; Chan BT; Lim E; Abdul Aziz YF; Liew YM
    Phys Med; 2020 Oct; 78():137-149. PubMed ID: 33007738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.